U.S. Food and Drug Administration Accepts Biologics Licensing Application for Opdivo (nivolumab) for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer

… of advanced squamous non-small cell lung cancer Bristol-Myers Squibb Company (NYSE:BMY … with advanced squamous non-small cell lung cancer (NSCLC) after prior therapy. The … in the squamous non-small cell lung cancer setting, Bristol-Myers Squibb marks another …